Dynamic Technology Lab Private LTD Jounce Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$2.8 - $7.67 $51,452 - $140,943	18,376 New	18,376 $56,000
Q1 2022 May 16, 2022	SELL	$6.01 - $8.54 $107,657 - $152,977	-17,913 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.11 - $9.64 $127,361 - $172,681	17,913 New	17,913 $150,000
Q2 2021 Aug 13, 2021	SELL	$6.58 - $10.66 $97,561 - $158,055	-14,827 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$6.73 - $13.87 $99,785 - $205,650	14,827 New	14,827 $152,000
Q4 2018 Feb 13, 2019	SELL	$2.69 - $6.71 $95,573 - $238,399	-35,529 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.5 - $8.37 $230,938 - $297,377	35,529 New	35,529 $231,000
Q2 2018 Aug 14, 2018	SELL	$7.27 - $21.88 $102,056 - $307,151	-14,038 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$13.4 - $28.4 $188,109 - $398,679	14,038 New	14,038 $313,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.